Lenisna
enisna is new generation biostimulating hybrid filler to fight aging and
preserve youth.
During the aging process, visible changes appear primarily on our skin. Due to the
constantly decreasing amount of collagen, elastic fibers and hyaluronic acid, the skin’s
firmness and elasticity decrease, and then it slowly sags and wrinkles appear. This process
can be reversed with the help of Lenisna filler, with regular applications the
youthful appearance can be restored and preserved.
Lenisna hybrid filler contain different concentrations of polylactic acid
(PDLLA) and non-crosslinked hyaluronic acid. The substance is able to strongly stimulate
the production of collagen in the skin and connective tissues and thereby increase the skin’s
firmness.
Biodegradable microparticles of PDLLA, or Poly D L-lactic acid, can prolong the effect of the filler for up to 1-2 years by activating collagen production.
It is a biocompatible, natural substance, so it does not burden the body and has a quick effect. Makes up for areas lacking volume.
Hyaluronic acid ensures optimal hydration of the skin, thereby contributing to the elasticity and firmness of tissues and the smoothing of wrinkles. It fills the space between collagen and elastic fibers.
As a result of the treatment, the structure of the skin is slowly transformed, strengthened and its appearance becomes more youthful.
Juvelook:
Juvelook contains 42.4 mg of polylactic acid and 7.5 mg of hyaluronic acid. It primarily improves the structure and quality of the skin. With its help, the unevenness of the skin surface can be significantly reduced, and its effect can last for 12-18 months.
Areas of application:
- wrinkles appearing on the skin,
- under eye circles,
- acne scars
- stretch marks
Lenisna:
Lenisna contains 170 mg of polylactic acid and 30 mg of hyaluronic acid. It is used to treat deeper, subcutaneous areas for volumization, to achieve a lifting effect and to highlight deep wrinkles and folds. Its effect can last for 18-24 months.
Areas of application:
- highlighting deep folds and wrinkles
- volumenization of the skinny face
- face lifting
- butt lift
Course of treatment
Lenisna hybrid filler is packaged in powder form. They must be diluted 24 hours before the treatment so that the active ingredient dissolves evenly during the treatment.
Lenisna is delivered into the deeper tissues with the help of a cannula. An anesthetic is used to minimize pain and discomfort during the treatment.
After applying Lenisna, it is recommended to gently massage the treated area in order to distribute the product evenly (using a suitable cream can help reduce the friction of the skin surface during the massage). It is recommended to massage the area around the treated area for 5 days, five times a day for five minutes, so that the performed correction has a natural effect.
Sun exposure of the surfaces exposed to the intervention should be moderated and the risk of UV radiation should be avoided until the initial swelling and redness have subsided.
Possible complications
After the injection(s), general reactions such as swelling, redness, pain, itching, discoloration and sensitivity may occur at the injection site. These symptoms usually go away on their own after 2-6 days of treatment.
Data from the use of PDLLA and clinical examinations also indicated the formation of nodules. Rarely, invisible but palpable nodules under the skin, as well as visible nodules, nodules around the eye socket, or hardening of the injection site, which may have been the result of overcorrection, have been reported. Lumps can sometimes be accompanied by an inflammatory condition or discoloration. The early appearance of subcutaneous nodules at the injection site (3-6 months after treatment) can be minimized by using a suitable dilution and administration technique.
Other, rarely occurring unwanted consequences can be: injection site inflammation, infection, late development of granulomas, allergic reactions, urticaria, skin hypertrophy and atrophy at the injection site, angioedema, capillary dilatation, cutaneous sarcoidosis, scarring, skin discoloration.
Taking anti-inflammatory drugs, blood thinners, or aspirin may cause bleeding or more bruising at the injection site.
There is no data on the safety of use of the product in pregnant mothers, nursing mothers and patients under the age of 18.
Other recommended treatments
Algeness
Algeness subdermal filler is the result of 15 years of scientific research: it is 100% natural, non-allergenic, and therefore one of the safest materials.
HArmonyCA
HArmonyCa, Allergan’s first dual-action product, combines two active ingredients, hyaluronic acid (HA) and calcium hydroxyapatite (CaHA) in one injection for the treatment of the facial area.
Karisma
The KARISMA treatment can be applied specifically to the problematic skin area or to the entire face/neck, thus helping to maintain the tone and elasticity of the skin. KARISMA is a biorestructuring and biostimulating soft filler that promotes skin regeneration, collagen production and elasticity.
Endolift®
Az Endolift® a legújabb orvos-esztétikai eljárás, ami lézerenergia segítségével rendkívül hatékony megoldást nyújt az arc és a test különböző pontjain megereszkedett bőr feszesítésére valamint a kisebb makacs zsírpárnák eltüntetésére.